ATLN Q4 2025 Earnings Significant EPS Miss Weighs on Stock Veru Inc Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline XPEL Q1 2026 Earnings Modest EPS Beat Amid Quiet Revenue Disclosure REVB Q1 2026 Earnings WiderthanExpected Loss Highlights PreRevenue Challenges GXAI Q1 2026 Earnings EPS Misses Estimates Stock Declines FibroBiologics FBLG Q1 2026 Earnings Narrow EPS Miss as PreRevenue Biotech Continues RD Investment